Protocol ยท August 26, 2026

Peptide filter sterilization: 0.22 micron syringe filters+

Peptide filter sterilization pushes a reconstituted peptide solution through a 0.22 micron membrane to remove bacteria before use. The method is reliable for sterility, but the membrane can also remove some of the peptide, and the filter material determines how much.

What peptide filter sterilization is

Peptide filter sterilization means pushing a reconstituted peptide solution through a membrane with a 0.22 micron (sometimes written 0.2 micron) pore rating before the solution is used. The filter sits between the syringe and the needle, or between a vial and a syringe during transfer. Bacteria are retained on the upstream side of the membrane; the filtrate that passes through is treated as sterile.

The technique is borrowed directly from pharmaceutical compounding, where it is one of the standard methods for producing a sterile injectable solution from a non-sterile or partially sterile starting material. For research peptides, it functions as an added barrier on top of, not a replacement for, the aseptic technique used during reconstitution.

How a 0.22 micron filter earns the sterilizing-grade label

Not every filter rated at 0.22 microns is automatically "sterilizing grade." The label is earned through a bacterial challenge test, not just a pore-size measurement. Lee et al. describe the standard in a 2010 paper in Applied and Environmental Microbiology (Lee A et al., Appl Environ Microbiol, PMC2812990): validation requires demonstrating removal of at least 7 log10 colony-forming units per square centimeter of Brevundimonas diminuta, an unusually small bacterium chosen specifically because it is difficult to retain. A membrane that passes this test removes 99.99999% of the challenge organism.

B. diminuta was not always the benchmark. Earlier compounding practice relied on 0.45 micron membranes, which were later shown to let some cells of this organism through under pressure. Carter tested hydrophilic PVDF and mixed cellulose ester membranes at both 0.22 and 0.45 microns against the standard challenge (Carter J, PDA J Pharm Sci Technol, 1996, PMID 8696777) as part of the work that helped settle 0.22 microns as the pharmaceutical standard still in use today.

What this means practically: a filter sold as "0.22 micron" for lab or industrial filtration is not automatically validated for sterilizing use. Filters marketed specifically as sterile or sterilizing-grade, most commonly with a PVDF or PES membrane in a single-use syringe housing, are the ones built to this standard.

The adsorption problem: what filtration does to the peptide

A sterilizing filter is good at stopping bacteria. It is not neutral toward the peptide itself. Membrane filters bind biomolecules to varying degrees, and for a low-concentration research solution, that binding can remove a meaningful fraction of the active material before it ever reaches the syringe.

Besheer tested four therapeutic proteins in dilute glucose and saline solutions against eight different in-line filter types (Besheer A, J Pharm Sci, 2017, PMID 28559043). Protein loss tracked filter material and solution composition more closely than it tracked which protein was being filtered. Charged membranes bound substantially more protein when the solution was glucose-based, where there is no salt to shield electrostatic attraction; the same membranes bound less in saline, where ions mask the surface charge. The practical takeaway carries over to peptides: adsorption is not a fixed percentage, it depends on the membrane, the diluent, and the concentration.

A second effect shows up under pressure rather than at the surface. Maa and Hsu, studying sterile filtration of recombinant human growth hormone, found that membrane fouling was driven less by particles already present in solution than by secondary aggregation forming inside the pores themselves during filtration (Maa YF, Hsu CC, Biotechnol Bioeng, 1996, PMID 18626959). pH, ionic strength, and surfactant presence all changed how much aggregation occurred. Pushing a solution through a filter too fast, at too high a pressure, can encourage this same in-pore aggregation regardless of the exact peptide involved.

Neither finding means filtration is a bad idea. It means the choice of filter material and the filtration technique are not incidental details.

Choosing a filter for a peptide solution

Filter membranes differ in how strongly they bind biomolecules. Hydrophilic PVDF (sold under trade names such as Durapore) and polyethersulfone (PES) are marketed as low-protein-binding materials and are the common choice for filtering protein and peptide solutions. Nylon carries a positive surface charge in its untreated form, which can increase retention of negatively charged biomolecules at low ionic strength, consistent with the charge-dependent binding Besheer's data showed. Cellulose acetate and cellulose nitrate membranes are older technology with comparatively higher general binding.

MilliporeSigma's Millex-GV unit, a PVDF sterilizing syringe filter often used in this context, is specified with a hold-up volume of 0.1 mL or less after air is purged from the housing and a working filtration range of 1 to 100 mL. For a typical reconstituted peptide batch of 1 to 3 mL, that 0.1 mL figure is not trivial. It is roughly the volume held in the membrane and housing after the plunger stops, and it needs to be accounted for when calculating final concentration for the dosing calculator.

Filters ship either dry or pre-wetted. A dry hydrophobic membrane will resist an aqueous solution and show high back-pressure on the plunger; forcing it can crack the housing seal. Hydrophilic PVDF membranes are treated to wet on contact with aqueous solutions, which is part of why they dominate this application over untreated PVDF or PTFE.

Filtering technique that does not waste the batch

Attach the filter to the syringe after drawing the peptide solution, then attach the needle to the outlet side of the filter. Push the plunger slowly and steadily. A sudden, high-pressure push is more likely to drive the in-pore aggregation described above and more likely to force the housing past its rated pressure limit, typically around 5 bar at room temperature for a standard syringe filter unit.

Adsorption to the membrane follows a saturation curve: binding sites fill as solution passes through, so the earliest fraction to cross the membrane experiences proportionally more loss than later fractions once the available binding sites are occupied. For very small filtration volumes, this front-loaded loss is one more reason a low-binding membrane matters more than it might at larger, industrial volumes.

Syringe filters are single-use devices. Reusing one across multiple reconstitution sessions reintroduces the exact contamination risk the filter was meant to remove, since the upstream membrane surface accumulates whatever it has already captured. For the reconstitution sequence this filtration step slots into, see the peptide reconstitution guide.

When filtration is worth the extra step

Filtration is not a mandatory step for every research peptide preparation. If a vial was reconstituted using sterile bacteriostatic water and consistent aseptic technique, contamination risk is already low, and pushing the solution through an additional membrane mainly adds a chance to lose peptide to adsorption without a proportional sterility benefit.

Filtration earns its place in a few specific situations: when the diluent or vial source is uncertain, when a solution will be stored and drawn from repeatedly over an extended period, or when a compound is being prepared from a non-sterile bulk source rather than a pre-sterilized lyophilized vial. In those cases, a low-binding PVDF or PES membrane, used once, at a controlled push rate, is the version of this step that loses the least material.

The most common mistake is treating filtration as a fix for contamination that already happened. A filter removes bacteria present in the solution at the moment of filtration; it does nothing for a peptide that degraded from a prior break in cold storage. It also does not undo a break in aseptic handling that occurred before filtration, if the outlet needle or the receiving container was itself contaminated afterward.

Filtering peptides in Indonesia's climate

Sterilizing syringe filters carry a manufacturer temperature limit, commonly around 45 degrees Celsius for a PVC-housed PVDF unit. A box of filters left in an un-air-conditioned storage room or a vehicle during transit in Jakarta or Bali can sit well above that threshold on a hot afternoon, particularly if the packaging is dark or exposed to direct sun. Repeated heat exposure can affect the housing seal and, over time, the membrane's wetting behavior, even if the filter looks physically intact.

High ambient humidity works in the opposite direction for the membrane itself: hydrophilic PVDF wets reliably in humid air, so priming is rarely the problem in a tropical setting. The practical adjustment is on the storage side, not the filtration technique: keep unopened filter stock in an air-conditioned space, away from direct sun, and check housings for warping or discoloration before use if they have spent time in a hot vehicle or warehouse. Filters bought from a supplier with cold-chain-aware Indonesia logistics are less likely to have already been exposed to this kind of heat cycling before they reach the bench.

Frequently asked questions

Do research peptides need to be filtered before use?

Not always. If a peptide was reconstituted with sterile bacteriostatic water using consistent aseptic technique, contamination risk is already low. Filtration adds value when the diluent source is uncertain, the solution will be stored and drawn from repeatedly, or the starting material was not pre-sterilized.

What pore size filter should be used for peptide solutions?

A 0.22 micron (sometimes labeled 0.2 micron) sterilizing-grade filter is the pharmaceutical standard. It is validated to remove at least 7 log10 CFU per square centimeter of Brevundimonas diminuta, a bacterium chosen because it is unusually difficult to retain.

Does filtering a peptide solution reduce its concentration?

Yes, to some degree. Membrane filters adsorb a fraction of dissolved biomolecules, and the effect is strongest for the first volume through the membrane before binding sites saturate. Low-binding PVDF or PES membranes minimize this loss compared to nylon or cellulose-based membranes.

Can a syringe filter be reused?

No. Syringe filters are single-use. The upstream membrane surface retains whatever bacteria and particulate it has already captured, so reusing a filter reintroduces the contamination risk the step was meant to eliminate.

Which filter material loses the least peptide to adsorption?

Hydrophilic PVDF (marketed under names such as Durapore) and polyethersulfone are described as low-protein-binding materials and are the common choice for peptide and protein solutions. Untreated nylon carries a positive surface charge that can bind more negatively charged biomolecules at low ionic strength.

Is a 0.22 micron filter the same thing as a sterile filter?

Not automatically. A filter needs to pass a bacterial challenge test against Brevundimonas diminuta to be certified sterilizing-grade. Filters sold for general lab filtration at a 0.22 micron rating are not always validated to this standard, so filters marketed specifically as sterile or sterilizing-grade should be used for this purpose.